A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Original Article

E. Vichinsky, C.C. Hoppe, K.I. Ataga, R.E. Ware, V. Nduba, A. El-Beshlawy, H. Hassab, M.M. Achebe, S. Alkindi, R.C. Brown, D.L. Diuguid, P. Telfer, D.A. Tsitsikas, A. Elghandour, V.R. Gordeuk, J. Kanter, M.R. Abboud, J. Lehrer-Graiwer, M. Tonda, A. Intondi, B. Tong, and J. Howard

N Engl J Med 2019;381:509-519

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/07/2019
Course expires: 
08/08/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, August 8, 2021 - 11:59pm.